Fig. 4From: Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancerPlasma cytokine levels of IL-6, IL-10 and IL-13 from mice with prophylactic chemo-immunotherapy and controls (upper graph). Differences between tumor-free and tumor-bearing mice (lower graphs). Plasma samples were collected at the experimental endpoint and cytokine levels were determined as described in material and methodsBack to article page